Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1994 Mar;49(3):213–217. doi: 10.1136/thx.49.3.213

Clinical relevance of testing for antineutrophil cytoplasm antibodies (ANCA) with a standard indirect immunofluorescence ANCA test in patients with upper or lower respiratory tract symptoms.

A Davenport 1, R J Lock 1, T B Wallington 1
PMCID: PMC1021148  PMID: 8202876

Abstract

BACKGROUND--Reports from specialist nephrological centres have suggested that the antineutrophil cytoplasm antibody (ANCA) test is highly specific and sensitive for patients with Wegener's granulomatosis. To determine the usefulness of the ANCA test in everyday respiratory practice the results of the test were audited in all patients in the south west of England with respiratory symptoms who underwent the test. METHODS--The results of all 335 patients who had presented with upper or lower respiratory tracts symptoms, or both, and were tested for ANCA by the indirect ANCA test in 1990, as recommended in the broadsheet of the British Association of Clinical Pathologists, were audited. Case notes and necropsy reports were available for review in 231 cases (69%), and in the remainder information was obtained by a standard questionnaire. RESULTS--There were 106 positive results, 45 (44%) from patients with Wegener's granulomatosis. The sensitivity and specificity of a positive ANCA test result in this study were 65% and 77% respectively. For a diagnosis of Wegener's granulomatosis the sensitivity and positive predictive accuracy of a positive cytoplasmic ANCA (c-ANCA) test were greater than of a positive perinuclear ANCA (p-ANCA) test. There were 61 positive tests in 266 patients who did not have Wegener's granulomatosis (23%); of these 27 were from patients with infection, 10 with fibrotic lung disease, nine with underlying connective tissue disease, seven with malignancy, and five following pulmonary emboli. Most of these positive ANCA results were p-ANCA (69%) rather than c-ANCA (31%). Serial ANCA requests were made in 15 cases of patients without Wegener's granulomatosis who had an initial positive ANCA test result. In all cases the ANCA tests subsequently became negative. CONCLUSIONS--In this study the sensitivity and specificity of a positive ANCA test result were less than that reported from specialised centres. However, the test was found to be useful in clinical practice, especially c-ANCA, in conjunction with clinical symptoms of respiratory pathology and evidence of renal disease.

Full text

PDF
213

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson G., Coles E. T., Crane M., Douglas A. C., Gibbs A. R., Geddes D. M., Peel E. T., Wood J. B. Wegener's granuloma. A series of 265 British cases seen between 1975 and 1985. A report by a sub-committee of the British Thoracic Society Research Committee. Q J Med. 1992 Jun;83(302):427–438. [PubMed] [Google Scholar]
  2. Davenport A. "False positive" perinuclear and cytoplasmic anti-neutrophil cytoplasmic antibody results leading to misdiagnosis of Wegener's granulomatosis and/or microscopic polyarteritis. Clin Nephrol. 1992 Mar;37(3):124–130. [PubMed] [Google Scholar]
  3. Davenport A., Grant P. J. False-positive autoantibodies in HIV infection. Lancet. 1990 Aug 4;336(8710):317–318. doi: 10.1016/0140-6736(90)91857-7. [DOI] [PubMed] [Google Scholar]
  4. Ewert B. H., Jennette J. C., Falk R. J. The pathogenic role of antineutrophil cytoplasmic autoantibodies. Am J Kidney Dis. 1991 Aug;18(2):188–195. doi: 10.1016/s0272-6386(12)80879-1. [DOI] [PubMed] [Google Scholar]
  5. FABER V., ELLING P., NORUP G., MANSA B., NISSEN N. I. AN ANTINUCLEAR FACTOR SPECIFIC FOR LEUCOCYTES. Lancet. 1964 Aug 15;2(7355):344–345. doi: 10.1016/s0140-6736(64)90283-1. [DOI] [PubMed] [Google Scholar]
  6. Fauci A. S., Haynes B. F., Katz P., Wolff S. M. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med. 1983 Jan;98(1):76–85. doi: 10.7326/0003-4819-98-1-76. [DOI] [PubMed] [Google Scholar]
  7. Fauci A. S., Wolff S. M. Wegener's granulomatosis: studies in eighteen patients and a review of the literature. Medicine (Baltimore) 1973 Nov;52(6):535–561. doi: 10.1097/00005792-197311000-00002. [DOI] [PubMed] [Google Scholar]
  8. Hagen E. C., Andrassy K., Chernok E., Daha M. R., Gaskin G., Gross W., Lesavre P., Lüdemann J., Pusey C. D., Rasmussen N. The value of indirect immunofluorescence and solid phase techniques for ANCA detection. A report on the first phase of an international cooperative study on the standardization of ANCA assays. EEC/BCR Group for ANCA Assay Standardization. J Immunol Methods. 1993 Feb 26;159(1-2):1–16. doi: 10.1016/0022-1759(93)90136-u. [DOI] [PubMed] [Google Scholar]
  9. Harrison D. J., Simpson R., Kharbanda R., Abernethy V. E., Nimmo G. Antibodies to neutrophil cytoplasmic antigens in Wegener's granulomatosis and other conditions. Thorax. 1989 May;44(5):373–377. doi: 10.1136/thx.44.5.373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Harrison D. J., Simpson R., Kharbanda R., Abernethy V. E., Nimmo G. Antibodies to neutrophil cytoplasmic antigens in Wegener's granulomatosis and other conditions. Thorax. 1989 May;44(5):373–377. doi: 10.1136/thx.44.5.373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lesavre P. Antineutrophil cytoplasmic autoantibodies antigen specificity. Am J Kidney Dis. 1991 Aug;18(2):159–163. doi: 10.1016/s0272-6386(12)80873-0. [DOI] [PubMed] [Google Scholar]
  12. Lock R. J. ACP Broadsheet No 143: January 1994. Detection of autoantibodies to neutrophil cytoplasmic antigens. J Clin Pathol. 1994 Jan;47(1):4–8. doi: 10.1136/jcp.47.1.4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. McDonald T. J., DeRemee R. A. Wegener's granulomatosis. Laryngoscope. 1983 Feb;93(2):220–231. doi: 10.1288/00005537-198302000-00020. [DOI] [PubMed] [Google Scholar]
  14. Nölle B., Specks U., Lüdemann J., Rohrbach M. S., DeRemee R. A., Gross W. L. Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener granulomatosis. Ann Intern Med. 1989 Jul 1;111(1):28–40. doi: 10.7326/0003-4819-111-1-28. [DOI] [PubMed] [Google Scholar]
  15. Tervaert J. W., van der Woude F. J., Fauci A. S., Ambrus J. L., Velosa J., Keane W. F., Meijer S., van der Giessen M., van der Hem G. K., The T. H. Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med. 1989 Nov;149(11):2461–2465. doi: 10.1001/archinte.149.11.2461. [DOI] [PubMed] [Google Scholar]
  16. Weidemann S., Andrassy K., Ritz E. ANCA in haemodialysis patients. Nephrol Dial Transplant. 1993;8(9):839–845. [PubMed] [Google Scholar]
  17. van der Woude F. J., Rasmussen N., Lobatto S., Wiik A., Permin H., van Es L. A., van der Giessen M., van der Hem G. K., The T. H. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet. 1985 Feb 23;1(8426):425–429. doi: 10.1016/s0140-6736(85)91147-x. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES